Both groups have been aggressively lobbying lawmakers in Washington.
Martin said it was unclear how BIDMC's liver program will ultimately be affected by this controversy.
She said, however, that she does not expect any policy changes any time soon.
Advertisement
Instead, she said she is concentrating on her goal to "get liver programs in Massachusettes to work together and get the cooperative spirit going in Boston."